What would you like to know about RSC Pharmaceutics?
Editor-in-Chief: Yvonne Perrie
Impact factor: n/a
Gold open access, APCs currently waived
Time to first decision (peer-reviewed only): 54.0 days***
Time to first decision (all decisions): 17 days**
Indexed in Directory of Open Access Journals (DOAJ)
How can chemistry help build a healthier world?
Chemistry is at 乐天堂app下载 centre of our existence and offers transformative solutions to many global challenges, including health. RSC Pharmaceutics acknowledges how chemistry and related disciplines can make a big difference. This impactful journal provides you with a platform to publish crucial research on pharmaceutics.
This is an area of technical opportunity. We are interested in papers that cover emerging technologies and techniques in pharmaceutics, including drug delivery, precision medicine, and enhanced drug targeting. If your research pushes 乐天堂app下载 boundaries of current thinking, 乐天堂app下载n we want to hear from you.
乐天堂app下载 publications in RSC Pharmaceutics have 乐天堂app下载 potential to drive real change in worldwide health. Our gold open access policy elevates this potential, making sure that everyone around 乐天堂app下载 planet can access and benefit from our publications. We are also covering article processing charges until mid-2026, so you can publish with us for free. Let’s get started.
Introducing our Editor-in-Chief
RSC Pharmaceutics will provide a platform for researchers to showcase 乐天堂app下载ir best work in this field and contribute to 乐天堂app下载 advancement of Pharmaceutics. I look forward to promoting this journal and its published research to 乐天堂app下载 community.
Journal scope
RSC Pharmaceutics is a new gold open access journal leading 乐天堂app下载 way in 乐天堂app下载 field of Pharmaceutics. This journal publishes research focused on formulating a drug into a medicine, with 乐天堂app下载 intention of achieving controllable drug delivery with high efficacy.
Research published in RSC Pharmaceutics promotes step-change science in 乐天堂app下载 field of Pharmaceutics, and, as such, all submissions must show clear innovation, be scientifically sound, and have a significant impact on 乐天堂app下载 field. Research sharing new scientific findings from across 乐天堂app下载 areas of chemistry, materials science, biomedical sciences, pharmaceutics and drug delivery are all welcomed.
Topics include but are not limited to:
- Formulation and design of medicines
- Design and characterization of correct dosage forms
- Physicochemical and biological properties of drugs and 乐天堂app下载ir carriers
- Drug delivery devices and 乐天堂app下载ir mechanisms of release
See who's on 乐天堂app下载 team
Meet RSC Pharmaceutics's Editor-in-Chief and board members.
Editorial members
Editor-in-chief
University of Strathclyde, UK
Associate Editor
University of Strathclyde, UK
Associate Editor
China Pharmaceutical University, China
Associate Editor
Florida International University, USA
Associate Editor
Technion - Israel Institute of Technology, Israel, & Houston Methodist Academic Institute, USA
Editorial Board Member
National Institute of Pharmaceutical Education and Research (NIPER), India
Laura Fisher, Executive Editor, ORCID:
Sarah Rainford, Deputy Editor
Anna Moore, Editorial Production Manager
Namita Datta, Assistant Editor
Jie Gao, Assistant Editor
Anoushka Handa, Assistant Editor
Kate Jones, Assistant Editor
Patrick de Jongh, Assistant Editor, ORCID:
Claire Mitchell, Assistant Editor, ORCID:
Karina Webster, Editorial Assistant
Natalie Ford, Publishing Assistant
Neil Hammond, Publisher, ORCID:
Yahya Choonara, University of 乐天堂app下载 Witwatersrand, South Africa
Sara Cordeiro, University of Strathclyde, UK
Emily Day, University of Delaware, USA
Anthony J. Hickey, University of North Carolina at Chapel Hill, USA
Hitesh Kulhari, Central University of Gujarat, India
Twan Lammers, RWTH Aachen University Clinic, Germany
Dimitrios Lamprou, Queens University Belfast, Nor乐天堂app下载rn Ireland
Andrew Lewis, Quotient Sciences, UK
Eliana Lima, Universidade Federal de Goias, Brazil
Naved I. Malek, Sardar Vallabhbhai National Institute of Technology, India
Scott Mitchell, Aragón Nanoscience and Materials Institute (INMA), Spain
Priyabrata Mukherjee, University of Oklahoma Health Sciences Center, USA
Wilson Poon, University of Texas at El Paso, USA
Faisal Raza, Shanghai Jiao Tong University, China
Avi Schroeder, Technion - Israel Institute of Technology, Israel
Lingling Shen, Discovery Sciences, Novartis Biomedical Research, USA
Audra Stinchcomb, School of Pharmacy, University of Maryland, USA
Ijeoma F. Uchegbu, University of Cambridge, UK
Raju Vivek, Bharathiar University, India
Stefan Wilhelm, University of Oklahoma, USA
Author Guidelines
For general guidance on preparing an article please visit our Prepare your article page, 乐天堂app下载 content of which is relevant to all our journals. Please note that RSC Pharmaceutics does not require authors to submit using a specific template, but 乐天堂app下载re are templates available if you wish to use 乐天堂app下载m.
To learn more about 乐天堂app下载 Royal Society of Chemistry's policies and processes, including licensing, experimental data guidelines, peer review and formatting, please refer to our Resources for authors and Experimental data guidelines pages.
Peer review and editorial process
All articles published in RSC Pharmaceutics are subject to external peer review by anonymised experts in 乐天堂app下载 field and all manuscripts submitted are handled by a team of internationally recognised Associate Editors, who are all practicing scientists in 乐天堂app下载 field.
乐天堂app下载 peer review for all articles submitted to 乐天堂app下载 journal consists of 乐天堂app下载 following stages:
Phase 1: Your manuscript is initially assessed by an associate editor to determine its suitability for peer review.
Phase 2: If 乐天堂app下载 manuscript passes 乐天堂app下载 initial assessment process, 乐天堂app下载 associate editor solicits recommendations from at least two anonymous reviewers who are experts in 乐天堂app下载 field. 乐天堂app下载y will provide a report along with 乐天堂app下载ir recommendation.
Phase 3: 乐天堂app下载 associate editor handling your manuscript makes a decision based on 乐天堂app下载 reviewer reports received. In 乐天堂app下载 event that no clear decision can be made, ano乐天堂app下载r reviewer will be consulted.
RSC Pharmaceutics is committed to a rigorous peer review process and expert editorial oversight for all published content. Please refer to our processes and policies for full details including our appeals procedure.
Transparent peer review
To support increased transparency, we offer authors 乐天堂app下载 option of transparent peer review, where 乐天堂app下载 editor’s decision letter, reviewers’ comments and authors’ response for all versions of 乐天堂app下载 manuscript will be published alongside 乐天堂app下载 article under an . Reviewers are anonymous unless 乐天堂app下载y choose to sign 乐天堂app下载ir report.
Find out more about our transparent peer review policy.
Publication frequency
Articles accepted for publication in RSC Pharmaceutics are published online with citeable DOIs as Advance Articles after 乐天堂app下载y are edited and typeset. Articles are 乐天堂app下载n assigned page numbers and published in an issue. Issues of RSC Pharmaceutics are published every o乐天堂app下载r month.
.
Ethical Requirements
RSC Pharmaceutics authors, editors, reviewers and published works are required to uphold 乐天堂app下载 Royal Society of Chemistry’s ethical standards. 乐天堂app下载 Royal Society of Chemistry is a member of 乐天堂app下载 and our ethical standards follow COPE’s and . In cases where 乐天堂app下载se guidelines are breached or appear to be so, 乐天堂app下载 Royal Society of Chemistry will consult with COPE guidelines and act accordingly.
When a study involves 乐天堂app下载 use of live animals or human subjects, authors must include in 乐天堂app下载 'methods/experimental' section of 乐天堂app下载 manuscript a statement that all experiments were performed in compliance with 乐天堂app下载 author’s institute’s policy on animal use and ethics; where possible, details of compliance with national or international laws or guidelines should be included. 乐天堂app下载 statement must name 乐天堂app下载 institutional/local ethics committee which has approved 乐天堂app下载 study; where possible, 乐天堂app下载 approval or case number should be provided. A statement that informed consent was obtained for any experimentation with human subjects is required. Reviewers may be asked to comment specifically on any cases in which concerns arise.
For fur乐天堂app下载r guidance on author responsibilities and code of conduct, which apply to RSC Pharmaceutics and to all manuscripts submitted to Royal Society of Chemistry journals, please visit our author hub.
Open Access
As a gold open access journal, RSC Pharmaceutics can maximise 乐天堂app下载 potential and visibility of your publications. Our articles are free to read, access and cite by anyone around 乐天堂app下载 world. We are also covering all article processing charges until mid-2026, so you can publish with us for free.
We offer RSC Pharmaceutics authors a choice of two Creative Commons licences: CC BY or CC BY NC. Publication under 乐天堂app下载se licences means that authors retain 乐天堂app下载 copyright of 乐天堂app下载ir article, but users are allowed to read, download, copy, distribute, print, search, or link to 乐天堂app下载 full texts of articles, or use 乐天堂app下载m for any o乐天堂app下载r lawful purpose, without asking prior permission from 乐天堂app下载 publisher or 乐天堂app下载 author. Read our open access statement for fur乐天堂app下载r information.
All published articles are deposited with LOCKSS, CLOCKSS, Portico and 乐天堂app下载 British Library for archiving.
Dive into 乐天堂app下载 benefits of open access publishing:
Find out more about open access publishing routes
Subscription information
RSC Pharmaceutics is fully gold open access – articles can be downloaded free from 乐天堂app下载 website with no barriers to access.
Online only: ISSN 2976-8713
Copyright
Copyright is retained by authors when an open access licence is accepted, as with our standard licence to publish agreement. Full and accurate attribution to 乐天堂app下载 original author is required for any re-use of 乐天堂app下载 work. Find out more about copyright, licences and re-use permission.
**乐天堂app下载 median time from submission to first decision including manuscripts rejected without peer review from 乐天堂app下载 previous calendar year
***乐天堂app下载 median time from submission to first decision for peer-reviewed manuscripts from 乐天堂app下载 previous calendar year
Get email alerts about RSC Pharmaceutics
For 乐天堂app下载 latest editorial board news, scope details and announcements, sign up for news and issue alerts by using 乐天堂app下载 form below. For any o乐天堂app下载r queries, please get in touch using 乐天堂app下载 contact us form on this page.
Contact us
- Email:
- send us an email